Home Biosimilar Antibodies Others Others antibody Glenzocimab (Anti-GP6 / Glycoprotein-6) For research use only.
Not for use in humans.

Glenzocimab (Anti-GP6 / Glycoprotein-6)

Synonyms: ACT017

Glenzocimab (Anti-GP6 / Glycoprotein-6) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke. MW: 145.5 KD.

Glenzocimab (Anti-GP6 / Glycoprotein-6)

Purity & Quality Control

≥99

Biological Activity

Description Glenzocimab (Anti-GP6 / Glycoprotein-6) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke. MW: 145.5 KD.

Product Details

CAS No. 2101829-58-5
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Glenzocimab (Anti-GP6 / Glycoprotein-6) | Glenzocimab (Anti-GP6 / Glycoprotein-6) supplier | purchase Glenzocimab (Anti-GP6 / Glycoprotein-6) | Glenzocimab (Anti-GP6 / Glycoprotein-6) cost | Glenzocimab (Anti-GP6 / Glycoprotein-6) manufacturer | order Glenzocimab (Anti-GP6 / Glycoprotein-6) | Glenzocimab (Anti-GP6 / Glycoprotein-6) distributor